These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
389 related articles for article (PubMed ID: 29498639)
1. The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma. Kimpel J; Urbiola C; Koske I; Tober R; Banki Z; Wollmann G; von Laer D Viruses; 2018 Mar; 10(3):. PubMed ID: 29498639 [TBL] [Abstract][Full Text] [Related]
2. Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment. Koske I; Rössler A; Pipperger L; Petersson M; Barnstorf I; Kimpel J; Tripp CH; Stoitzner P; Bánki Z; von Laer D Int J Cancer; 2019 Oct; 145(7):1958-1969. PubMed ID: 30972741 [TBL] [Abstract][Full Text] [Related]
3. Oncolytic activity of the rhabdovirus VSV-GP against prostate cancer. Urbiola C; Santer FR; Petersson M; van der Pluijm G; Horninger W; Erlmann P; Wollmann G; Kimpel J; Culig Z; von Laer D Int J Cancer; 2018 Oct; 143(7):1786-1796. PubMed ID: 29696636 [TBL] [Abstract][Full Text] [Related]
4. Xenoantigen-Dependent Complement-Mediated Neutralization of Lymphocytic Choriomeningitis Virus Glycoprotein-Pseudotyped Vesicular Stomatitis Virus in Human Serum. Pipperger L; Koske I; Wild N; Müllauer B; Krenn D; Stoiber H; Wollmann G; Kimpel J; von Laer D; Bánki Z J Virol; 2019 Sep; 93(18):. PubMed ID: 31243134 [TBL] [Abstract][Full Text] [Related]
5. Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus. Blackham AU; Northrup SA; Willingham M; D'Agostino RB; Lyles DS; Stewart JH Surgery; 2013 Mar; 153(3):333-43. PubMed ID: 23102637 [TBL] [Abstract][Full Text] [Related]
10. Vesicular stomatitis virus variants selectively infect and kill human melanomas but not normal melanocytes. Wollmann G; Davis JN; Bosenberg MW; van den Pol AN J Virol; 2013 Jun; 87(12):6644-59. PubMed ID: 23552414 [TBL] [Abstract][Full Text] [Related]
12. Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma. Murphy AM; Besmer DM; Moerdyk-Schauwecker M; Moestl N; Ornelles DA; Mukherjee P; Grdzelishvili VZ J Virol; 2012 Mar; 86(6):3073-87. PubMed ID: 22238308 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: potential role of human papilloma virus infection. Le Boeuf F; Niknejad N; Wang J; Auer R; Weberpals JI; Bell JC; Dimitroulakos J Int J Cancer; 2012 Aug; 131(3):E204-15. PubMed ID: 22173567 [TBL] [Abstract][Full Text] [Related]
14. Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP. Vijver SV; Danklmaier S; Pipperger L; Gronauer R; Floriani G; Hackl H; Das K; Wollmann G Front Immunol; 2022; 13():1100730. PubMed ID: 36741416 [TBL] [Abstract][Full Text] [Related]
15. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma. Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179 [TBL] [Abstract][Full Text] [Related]
16. Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants. Pipperger L; Riepler L; Kimpel J; Siller A; Stoitzner P; Bánki Z; von Laer D Oncoimmunology; 2021; 10(1):1959140. PubMed ID: 34484872 [TBL] [Abstract][Full Text] [Related]
17. Triptolide-mediated inhibition of interferon signaling enhances vesicular stomatitis virus-based oncolysis. Ben Yebdri F; Van Grevenynghe J; Tang VA; Goulet ML; Wu JH; Stojdl DF; Hiscott J; Lin R Mol Ther; 2013 Nov; 21(11):2043-53. PubMed ID: 23985699 [TBL] [Abstract][Full Text] [Related]
18. Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling. Moerdyk-Schauwecker M; Shah NR; Murphy AM; Hastie E; Mukherjee P; Grdzelishvili VZ Virology; 2013 Feb; 436(1):221-34. PubMed ID: 23246628 [TBL] [Abstract][Full Text] [Related]
19. Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers. Fehl DJ; Ahmed M Virus Res; 2017 Jan; 228():14-23. PubMed ID: 27865863 [TBL] [Abstract][Full Text] [Related]